Fibronostics is a company that develops a non-invasive diagnostic testing system intended to provide algorithm-based health monitoring solutions. Its system focuses on assessing liver disease existence/progression and chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. The company aims to allow doctors as well as patients to detect any early signs in order to facilitate efficient monitoring of diseases.